{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-002292","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2026-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.726781+00:00","generated_at":"2026-05-16T10:08:50.024995+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"XTL to acquire 85% of Beyond Air's NeuroNOS for equity, $1M cash, up to $32.5M milestones","bullets":["XTL acquires 85% of NeuroNOS for 19.9% of XTL's share capital, $1M cash, and up to $32.5M in milestone payments.","NeuroNOS platform targets core autism pathophysiology; two Nobel Laureates join scientific team.","NeuroNOS holds two FDA Orphan Drug Designations for Phelan-McDermid Syndrome and Glioblastoma.","Beyond Air becomes significant XTL shareholder, retains 15% of NeuroNOS; deal valued up to $32.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-002292","json":"https://secwatch.observer/filing/0001493152-26-002292.json","markdown":"https://secwatch.observer/filing/0001493152-26-002292.md","text":"https://secwatch.observer/filing/0001493152-26-002292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315226002292/0001493152-26-002292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315226002292/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:08:50.024995+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}